Rates of hospitalization pre- and post-total pancreatectomy with islet autotransplantation for patients with pancreatitis - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Hospitalization Trends Before and After Total Pancreatectomy with Islet Autotransplantation in Patients with Pancreatitis

  • By

  • Niveditha Jagadesh

  • Anne Eaton

  • Megan B. Ghai

  • Guru Trikudanathan

  • Kathryn D. Robinson

  • Vikesh K. Singh

  • Jaimie D. Nathan

  • Srinath Chinnakotla

  • Maisam Abu-El-Haija

  • Syed A. Ahmad

  • Timothy B. Gardner

  • Luis F. Lara

  • Katherine Morgan

  • Sri Prakash Mokshagundam

  • Bashoo Naziruddin

  • Andrew Posselt

  • Martin Wijkstrom

  • Piotr Witkowski

  • Gregory Beilman

  • Melena D. Bellin

  • August 26, 2026

Share

Original Source(s)

Rates of hospitalization pre- and post-total pancreatectomy with islet autotransplantation for patients with pancreatitis

  • by Niveditha Jagadesh, Anne Eaton, Megan B. Ghai, Guru Trikudanathan, Kathryn D. Robinson, Vikesh K. Singh, Jaimie D. Nathan, Srinath Chinnakotla, Maisam Abu-El-Haija, Syed A. Ahmad, Timothy B. Gardner, Luis F. Lara, Katherine Morgan, Sri Prakash Mokshagundam, Bashoo Naziruddin, Andrew Posselt, Martin Wijkstrom, Piotr Witkowski, Gregory Beilman, Melena D. Bellin

  • August 26, 2026

Related Content

Outcomes of emergent hiatal hernia repair: does specialty matter?

Correction: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects

FDA Approves Daraxonrasib for Metastatic Pancreatic Cancer Following Landmark Clinical Trial Led by Dana-Farber

he U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.

  • by

  • August 26, 2026

  • 5 min